Exclusive

Publication

Byline

Location

US Patent Issued to Mallinckrodt Pharmaceuticals Ireland on Oct. 6 for "Pulmonary arterial compliance with inhaled nitric oxide (iNO) treatment" (New Jersey Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,968, issued on Oct. 6, was assigned to Mallinckrodt Pharmaceuticals Ireland Ltd. (Dublin). "Pulmonary arterial compliance with inhaled nitri... Read More


US Patent Issued on Oct. 6 for "Intravenous physiological solution to optimize fluid therapy in patients" (Missouri Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,969, issued on Oct. 6. "Intravenous physiological solution to optimize fluid therapy in patients" was invented by Adnan I. Qureshi (Columbia... Read More


US Patent Issued to JOY MEDICAL DEVICES on Oct. 6 for "Use of porous calcium-based granules for promoting healing of an intra-articular or peri-articular fracture of a fractured bone" (American, Taiwanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,970, issued on Oct. 6, was assigned to JOY MEDICAL DEVICES Corp. (Kaohsiung, Taiwan). "Use of porous calcium-based granules for promoting he... Read More


US Patent Issued to Mayo Foundation for Medical Education and Research on Oct. 6 for "Antioxidant and antiviral compositions and methods" (Minnesota Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,971, issued on Oct. 6, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.). "Antioxidant and antiviral com... Read More


US Patent Issued to GUANGZHOU BIO-GENE TECHNOLOGY on Oct. 6 for "Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof18255119" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,972, issued on Oct. 6, was assigned to GUANGZHOU BIO-GENE TECHNOLOGY Co. LTD (Guangdong, China). "Anti-Claudin18.2 antigen-binding fragment ... Read More


US Patent Issued to ABELZETA on Oct. 6 for "Bispecific chimeric antigen receptors targeting CD20 and BCMA" (Maryland, Maine Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,973, issued on Oct. 6, was assigned to ABELZETA INC. (Rockville, Md.). "Bispecific chimeric antigen receptors targeting CD20 and BCMA" was i... Read More


US Patent Issued to OSAKA UNIVERSITY on Oct. 6 for "Composition for use in treating dystrophic epidermolysis bullosa" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,974, issued on Oct. 6, was assigned to OSAKA UNIVERSITY (Osaka, Japan). "Composition for use in treating dystrophic epidermolysis bullosa" w... Read More


US Patent Issued to FUJIFILM WAKO PURE CHEMICAL on Oct. 6 for "Anti-inflammatory agent and method of producing extracellular vesicle having anti-inflammatory action" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,975, issued on Oct. 6, was assigned to FUJIFILM WAKO PURE CHEMICAL Corp. (Osaka, Japan). "Anti-inflammatory agent and method of producing ex... Read More


US Patent Issued to The Regents of the University of California on Oct. 6 for "Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,976, issued on Oct. 6, was assigned to The Regents of the University of California (Oakland, Calif.). "Induced pluripotent stem cell derived... Read More


US Patent Issued to Sana Biotechnology, The Children's Medical Center on Oct. 6 for "Methods and compositions of chondrisomes" (American, Canadian Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,977, issued on Oct. 6, was assigned to Sana Biotechnology Inc. (Seattle) and The Children's Medical Center Corp. (Boston). "Methods and comp... Read More